Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | THRB | P10828 | 1/20 | 0.32 |
| ▸ | BLM | P54132 | 1/20 | 0.32 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 2/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL428282 | 0.86 | TSHR (0.46) | TSHRTDP1MAPTSMN1; SMN2 | |
| SCHEMBL469796 | 0.73 | MAPT (0.38) | TSHRTDP1MAPTSMN1; SMN2 | |
| SCHEMBL16558118 | 0.72 | TSHR (0.36) | TSHRTDP1MAPT | |
| SCHEMBL469846 | 0.69 | MAPT (0.35) | TSHRLMNABLMMAPTSMN1; SMN2 | |
| SCHEMBL2741119 | 0.64 | TDP1 (0.64) | TSHRTDP1LMNACYP1A2THRB | |
| Ammonia Solution, Strong SCHEMBL9875109 | 0.62 | SLC29A1 (0.33) | TSHRTDP1LMNACYP1A2THRB | |
| SCHEMBL62454 | 0.61 | MAPT (0.41) | CYP1A2MAPT | |
| SCHEMBL2338559 | 0.61 | MAPT (0.66) | TSHRTDP1MAPTSMN1; SMN2 | |
| Methyl Alcohol SCHEMBL7196036 | 0.60 | SLC29A1 (0.37) | TSHRTDP1LMNACYP1A2THRB | |
| SCHEMBL469797 | 0.58 | TSHR (0.44) | TSHRTDP1MAPTSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9221960-B2 | Multifunctional melamine epoxy resins, methylols and amines | EMPIRE TECHNOLOGY DEVELOPMENT LLC (US) | 2015-12-29 | — | — | US | disclosed |
| US-20150073103-A1 | MULTIFUNCTIONAL MELAMINE EPOXY RESINS, METHYLOLS AND AMINES | CRESTLINE DIRECT FINANCE, L.P. | 2015-03-12 | — | — | US | disclosed |
| US-8911858-B2 | Multifunctional melamine epoxy resins, methylols and amines | EMPIRE TECHNOLOGY DEVELOPMENT LLC (US) | 2014-12-16 | — | — | US | disclosed |
| US-8911858-B2 | Multifunctional melamine epoxy resins, methylols and amines | EMPIRE TECHNOLOGY DEVELOPMENT LLC (US) | 2014-12-16 | — | — | US | disclosed |
| US-20140179838-A1 | MULTIFUNCTIONAL MELAMINE EPOXY RESINS, METHYLOLS AND AMINES | EMPIRE TECHNOLOGY DEVELOPMENT LLC (US) | 2014-06-26 | — | — | US | disclosed |
| US-20140179838-A1 | MULTIFUNCTIONAL MELAMINE EPOXY RESINS, METHYLOLS AND AMINES | EMPIRE TECHNOLOGY DEVELOPMENT LLC (US) | 2014-06-26 | — | — | US | disclosed |
| WO-2014070155-A1 | MULTIFUNCTIONAL MELAMINE EPOXY RESINS, METHYLOLS AND AMINES | EMPIRE TECHNOLOGY DEVELOPMENT LLC (US) | 2014-05-08 | — | — | WO | disclosed |
| WO-2012033607-A1 | METHODS OF REMOVING CARBON DIOXIDE AND SORBENTS FOR SAME | BATTELLE ENERGY ALLIANCE, LLC (US) | 2012-03-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140179838-A1 | MULTIFUNCTIONAL MELAMINE EPOXY RESINS, METHYLOLS AND AMINES | PNMT, HNMT, NNMT | TSHR 2435/4885TDP1 2104/4885LMNA 1209/4885 |
| US-20150073103-A1 | MULTIFUNCTIONAL MELAMINE EPOXY RESINS, METHYLOLS AND AMINES | PNMT, HNMT, NNMT | TSHR 2435/4885TDP1 2104/4885LMNA 1209/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.